Randomized, controlled trial testing the effectiveness and safety of 2.5% and 5% benzoyl peroxide for the treatment of pitted keratolysis

The appropriate dosage and duration of topical benzoyl peroxide gel (BP) treatment of pitted keratolysis (PK) is controversial. To compare the effectiveness and safety of topical 2.5% and 5% BP for the treatment of PK. This randomized, controlled trial was conducted at Chumpol Naval Rating School, C...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of dermatological treatment Vol. 32; no. 7; pp. 851 - 854
Main Authors Leeyaphan, Charussri, Limphoka, Pichaya, Kiratiwongwan, Rungsima, Ongsri, Punyawee, Bunyaratavej, Sumanas
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 03.10.2021
Taylor & Francis Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The appropriate dosage and duration of topical benzoyl peroxide gel (BP) treatment of pitted keratolysis (PK) is controversial. To compare the effectiveness and safety of topical 2.5% and 5% BP for the treatment of PK. This randomized, controlled trial was conducted at Chumpol Naval Rating School, Chonburi, Thailand. Naval rating cadets with PK were randomly assigned to either a 2.5% or a 5% BP group and were requested to apply the related medication on each sole once daily, for 2 weeks. All 42 and 47 participants who were treated with 2.5% and 5% BP, respectively, were included in the later analysis. Self-evaluation of the foot odor level using a visual analog scale (VAS) showed significant decreases for both groups (p<.001). The pitted lesions were evaluated by dermatologists and found to have improved in the 2.5% and 5% BP groups (69.0% versus 63.8%, respectively; p=.457). Side effects did not statistically differ between the two groups (p>.05). Either 2.5% or 5% BP can be used for the treatment of PK and foot malodor. Due to the similarities in their efficacies and side effects, the use of 2.5% BP may be preferable.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-News-3
content type line 23
ISSN:0954-6634
1471-1753
DOI:10.1080/09546634.2019.1708244